Profile picture

Professor Shilong Zhong

Guangdong Provincial People's Hospital, Guangzhou (China)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-1301, an oral PCSK9 inhibitor, in healthy participants: a first-in-human, randomized, double-blind, placebo-controlled phaseⅠtrial
Presentation
Safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-1301, an oral PCSK9 inhibitor, in healthy participants: a first-in-human, randomized, double-blind, placebo-controlled phaseⅠtrial
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources